AngioDynamics to Present at the Barclays Global Healthcare Conference
Get Alerts ANGO Hot Sheet
Join SI Premium – FREE
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Michael C. Greiner, Executive Vice President and Chief Financial Officer, will present at the Barclays Global Healthcare Conference at 4:20 p.m. ET on Wednesday, March 13, 2019 in Miami Beach, FL.
A live webcast of the presentation will be accessible through the âInvestorsâ section of the Companyâs website at www.angiodynamics.com and will be available for replay following the event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamicsâ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190226005790/en/
Investor:
AngioDynamics, Inc.
Michael C. Greiner, Executive
Vice President & CFO
(518) 795-1821
Source: AngioDynamics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beyond the Screen: Hero Esports CEO Highlights Role of Esports in Creating Shared Urban Experiences at LEAP East 2026
- NBPE Announces Transaction in Own Shares
- Anoto receives first commercial purchase order starting the phased global rollout of LAMY co-branded product
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share